Statutory Requirements for Disclosure of Breast Cancer Treatment Alternatives
Nayfield, Susan G.
Bongiovanni, Gregory C.
Alciati, Marianne Haenlein
Fischer, Ruth A.
Journal of the National Cancer Institute. 1994 Aug 17; 86(16): 1202-1208.
Alternatives; Attitudes; Breast Cancer; Cancer; Consent; Decision Making; Disclosure; Drugs; Females; Government; Hormones; Information Dissemination; Informed Consent; Legal Aspects; Legislation; Patient Care; Patient Participation; Physicians; Radiology; Research; Risks and Benefits; State Government; Surgery; Therapeutic Research;
Showing items related by title, author, creator and subject.
Nayfield, Susan G.; Bongiovanni, Gregory C.; Alciati, Marianne Haenlein; Fischer, Ruth A.; Bergner, Lawrence (1994-08-17)
Ethical and Scientific Considerations for Chemoprevention Research in Cohorts at Genetic Risk for Breast Cancer Nayfield, Susan G. (1996)Identification of cohorts at genetic risk for cancer offers unique research opportunities to explore the steps in carcinogenesis, from the inheritance of a predisposing mutation to the development of preinvasive lesions ...
Ethical and Scientific Considerations for Chemoprevention Research in Cohorts at Genetic Risk for Breast Cancer Nayfield, Susan G. (1996)